di
Thriemer, Kamala,
Degaga, Tamiru Shibru,
Christian, Michael,
Alam, Mohammad Shafiul,
Ley, Benedikt,
Hossain, Mohammad Sharif,
Kibria, Mohammad Golam,
Tego, Tedla Teferi,
Abate, Dagimawie Tadesse,
Weston, Sophie,
Karahalios, Amalia,
Rajasekhar, Megha,
Simpson, Julie A.,
Rumaseb, Angela,
Mnjala, Hellen,
Lee, Grant,
Anose, Rodas Temesgen,
Kidane, Fitsum Getahun,
Woyessa, Adugna,
Baird, Kevin,
Sutanto, Inge,
Hailu, Asrat,
Price, Ric N.
Pubblicazione 2022
“...METHODS: This is a multicentre, health care facility-based, randomized, controlled, open-label trial in Bangladesh,
Indonesia and Ethiopia. Patients with uncomplicated falciparum malaria, G6PD activity of ≥70% of the adjusted male median (AMM) and haemoglobin levels ≥8g/dl are recruited into the study and randomized to either receive standard schizonticidal treatment plus 7-day high dose primaquine (total dose 7mg/kg) or standard care in a 1:1 ratio. ...”
Testo
Testo
Testo
Online
Articolo
testo
